David BAUER,Matthew BIO,Melanie COOKE,Katrina W. COPELAND,Matthew PETERSON,Michele POTASHMAN,Roman SHIMANOVICH,Helming TAN
申请号：
US15966157
公开号：
US20180244696A1
申请日:
2018.04.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are novel polymorphic forms and co-crystals of a compound useful in the treatment, prevention, or amelioration of cancer. In particular, the invention provides polymorphs and co-crystals of 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one, which is an inhibitor of c-Met.
